Evidence map›Paper›PMID 29117330›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Neonatal Encephalopathy With Group B Streptococcal Disease Worldwide: Systematic Review, Investigator Group Datasets, and Meta-analysis.

Cally J Tann, Kathryn A Martinello, Samantha Sadoo, Joy E Lawn, Anna C Seale, Maira Vega-Poblete, Neal J Russell, Carol J Baker, Linda Bartlett, Clare Cutland and 11 more

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 11 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 11 syntheses or guidelines pooled it, 69 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  5. Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  6. Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  7. Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  8. Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  9. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  10. Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  11. Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  12. Trial
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 15 institutions in 7 countries.

Cally J TannMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Kathryn A MartinelloNeonatal Medicine, University College London Hospitals NHS Foundation Trust, United Kingdom.
Samantha SadooMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Joy E LawnMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Anna C SealeMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Maira Vega-PobleteNeonatal Medicine, University College London Hospitals NHS Foundation Trust, United Kingdom.
Neal J RussellMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Carol J BakerDepartments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
Linda BartlettDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Clare CutlandMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Michael G GravettGlobal Alliance to Prevent Prematurity and Stillbirth, Seattle, Washington.
Margaret IpDepartment of Microbiology, Faculty of Medicine, Chinese University of Hong Kong.
Kirsty Le DoareCentre for International Child Health, Imperial College London, United Kingdom.
Shabir A MadhiMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Craig E RubensGlobal Alliance to Prevent Prematurity and Stillbirth, Seattle, Washington.
Samir K SahaBangladesh Institute of Child Health, Dhaka.
Stephanie SchragNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Ajoke Sobanjo-Ter MeulenBill & Melinda Gates Foundation, Seattle, Washington.
Johan VekemansWorld Health Organization, Geneva, Switzerland.
Paul T HeathVaccine Institute, Institute for Infection and Immunity, St George's Hospital, University of London and St George's University Hospitals NHS Foundation Trust, United Kingdom.
GBS Neonatal Encephalopathy Investigator Group
University College London Hospitals NHS Foundation Trust · GBUniversity of London · GBUniversity of Washington · USBaylor College of Medicine · USCenters for Disease Control and Prevention · USChild Health Research Foundation · BDChinese University of Hong Kong · HKGates Foundation · USHaramaya University · ETJohns Hopkins University · USKing's College London · GBLondon School of Hygiene & Tropical Medicine · GBNational Health Laboratory Service · ZAUniversity of the Witwatersrand · ZAWorld Health Organization · CH

Funding

Medical Research Council G0100126Medical Research Council G0200270Medical Research Council MC_UP_1204/9Medical Research Council MR/K006355/1Medical Research Council MR/N008405/1Wellcome Trust 205184/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

backgroundNeonatal encephalopathy (NE) is a leading cause of child mortality and longer-term impairment. Infection can sensitize the newborn brain to injury; however, the role of group B streptococcal (GBS) disease has not been reviewed. This paper is the ninth in an 11-article series estimating the burden of GBS disease; here we aim to assess the proportion of GBS in NE cases.

methodsWe conducted systematic literature reviews (PubMed/Medline, Embase, Latin American and Caribbean Health Sciences Literature [LILACS], World Health Organization Library Information System [WHOLIS], and Scopus) and sought unpublished data from investigator groups reporting GBS-associated NE. Meta-analyses estimated the proportion of GBS disease in NE and mortality risk. UK population-level data estimated the incidence of GBS-associated NE.

resultsFour published and 25 unpublished datasets were identified from 13 countries (N = 10436). The proportion of NE associated with GBS was 0.58% (95% confidence interval [CI], 0.18%-.98%). Mortality was significantly increased in GBS-associated NE vs NE alone (risk ratio, 2.07 [95% CI, 1.47-2.91]). This equates to a UK incidence of GBS-associated NE of 0.019 per 1000 live births.

conclusionsThe consistent increased proportion of GBS disease in NE and significant increased risk of mortality provides evidence that GBS infection contributes to NE. Increased information regarding this and other organisms is important to inform interventions, especially in low- and middle-resource contexts.

Indexed as

Streptococcus agalactiaeBrain DiseasesHumansIncidenceInfant, NewbornInfant, Newborn, DiseasesRisk FactorsStreptococcal Infectionsgroup B Streptococcushypoxic-ischemic encephalopathyneonatal encephalopathynewborntherapeutic hypothermia

Identifiers

PMID29117330
PMCPMC5850525
OpenAlexW2782245130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.